We are live on ! Find out more
NME

Notis-McConarty Edward Portfolio holdings

AUM $201M
1-Year Est. Return 18.67%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+18.67%
3 Year Est. Return
+65.19%
5 Year Est. Return
+89.79%
10 Year Est. Return
+322.21%
AUM
$146M
AUM Growth
+$4.19M
Cap. Flow
-$2.13M
Cap. Flow %
-1.46%
Top 10 Hldgs %
30.9%
Holding
120
New
4
Increased
17
Reduced
19
Closed
5

Top Buys

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$569K
2
HP icon
Helmerich & Payne
HP
+$280K
3
XYL icon
Xylem
XYL
+$272K
4
RTX icon
RTX Corp
RTX
+$222K
5
TXN icon
Texas Instruments
TXN
+$207K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.8M
2
XOM icon
ExxonMobil
XOM
+$706K
3
ADP icon
Automatic Data Processing
ADP
+$468K
4
QCOM icon
Qualcomm
QCOM
+$325K
5
LH icon
Labcorp
LH
+$278K

Sector Composition

Rank Sector Weight
1 Healthcare 22.96%
2 Technology 21.99%
3 Industrials 17.97%
4 Energy 9.95%
5 Consumer Staples 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
101
Cigna
CI
$77.1B
$196K 0.13%
1,900
ADBE icon
102
Adobe
ADBE
$95.4B
$173K 0.12%
2,380
OVV icon
103
Ovintiv
OVV
$17B
$169K 0.12%
2,440
GIS icon
104
General Mills
GIS
$19.5B
$160K 0.11%
3,000
MCK icon
105
McKesson
MCK
$99.9B
$156K 0.11%
750
ALXN
106
DELISTED
Alexion Pharmaceuticals
ALXN
$139K 0.1%
750
SBUX icon
107
Starbucks
SBUX
$119B
$135K 0.09%
3,300
BXP icon
108
Boston Properties
BXP
$11B
$129K 0.09%
1,000
NVO
109
Novo Nordisk
NVO
$219B
$106K 0.07%
5,000
DOV icon
110
Dover
DOV
$27.4B
$72K 0.05%
1,238
GSK icon
111
GSK
GSK
$104B
-31,336
Closed -$1.8M
LH icon
112
Labcorp
LH
$24.5B
-3,178
Closed -$278K
OII icon
113
Oceaneering
OII
$5.15B
-4,000
Closed -$261K
SDRL
114
DELISTED
Seadrill Limited Common Stock
SDRL
-30
Closed -$217K
KMP
115
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
-1,000
Closed -$93K

Similar funds

Notis-McConarty Edward's Q4 2014 Portfolio in Review

As of Q4 2014, Notis-McConarty Edward held 120 positions worth $146M, up 3% from $142M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Notis-McConarty Edward's Q4 2014 filing shows 4 new, 17 increased, 19 reduced and 5 closed positions. Its largest new stake was CDK Global, Inc.: 16,070 shares worth $655K. The largest sale was GSK, an estimated $1.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.

  • Notis-McConarty Edward's largest Q4 2014 buy was CDK Global, Inc.: 16,070 shares worth $655K.
  • Notis-McConarty Edward added most to Helmerich & Payne in Q4 2014, an estimated $280K increase.
  • Notis-McConarty Edward's biggest Q4 2014 reduction was ExxonMobil, cutting an estimated $706K.
  • Notis-McConarty Edward fully exited GSK in Q4 2014, selling an estimated $1.8M.
  • Notis-McConarty Edward's ten largest holdings make up 31% of its $146M portfolio in Q4 2014.
  • Notis-McConarty Edward opened 4 new positions and closed 5 in Q4 2014.
  • Notis-McConarty Edward's portfolio value rose 3% quarter-over-quarter to $146M.

Based on Notis-McConarty Edward's 13F filing for Q4 2014, filed 13 Feb 2015.